Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859
NCT02766621
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
PF-06823859
DRUG:
Placebo injection SC/IV
Sponsor
Pfizer